Huntington’s disease: from huntingtin function and dysfunction to therapeutic strategies

Author： Borrell-Pagès M.   Zala D.   Humbert S.   Saudou F.  

Publisher： Springer Publishing Company

ISSN： 1420-682X

Source： Cellular and Molecular Life Sciences CMLS, Vol.63, Iss.22, 2006-11, pp. : 2642-2660

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

CRISPR-Cas9 Mediated Gene-Silencing of the Mutant Huntingtin Gene in an In Vitro Model of Huntington’s Disease

By Kolli Nivya   Lu Ming   Maiti Panchanan   Rossignol Julien   Dunbar Gary L.  

International Journal of Molecular Sciences, Vol. 18, Iss. 4, 2017-04 ,pp. : 754-754

MDPI

Access to resources Recommend Favorite

Neuropsychiatric Burden in Huntington’s Disease

By Paoli Ricardo Augusto   Botturi Andrea   Ciammola Andrea   Silani Vincenzo   Prunas Cecilia   Lucchiari Claudio   Zugno Elisa   Caletti Elisabetta  

Brain Sciences, Vol. 7, Iss. 6, 2017-06 ,pp. : 67-67

MDPI

Access to resources Recommend Favorite

Is the ubiquitin-proteasome system impaired in Huntington’s disease?

By Ortega Z.   Díaz-Hernández M.   Lucas J.  

Cellular and Molecular Life Sciences CMLS, Vol. 64, Iss. 17, 2007-09 ,pp. : 2245-2257

Springer Publishing Company

Access to resources Recommend Favorite

Changes in the store-dependent calcium influx in a cellular model of Huntington’s disease

By Glushankova L.   Zimina O.   Vigont V.   Mozhaeva G.   Bezprozvanny I.   Kaznacheeva E.  

Doklady Biological Sciences, Vol. 433, Iss. 1, 2010-08 ,pp. : 293-295

MAIK Nauka/Interperiodica

Access to resources Recommend Favorite

Use of Genetically Altered Stem Cells for the Treatment of Huntington’s Disease

By Crane Andrew T.   Rossignol Julien   Dunbar Gary L.  

Brain Sciences, Vol. 4, Iss. 1, 2014-03 ,pp. : 202-219

MDPI

Access to resources Recommend Favorite